These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 18424662
1. Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells. Kel JM, Slütter B, Drijfhout JW, Koning F, Nagelkerken L. J Leukoc Biol; 2008 Jul; 84(1):182-90. PubMed ID: 18424662 [Abstract] [Full Text] [Related]
2. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis. Luca ME, Kel JM, van Rijs W, Wouter Drijfhout J, Koning F, Nagelkerken L. J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471 [Abstract] [Full Text] [Related]
3. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). Kaushansky N, Eisenstein M, Oved JH, Ben-Nun A. Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757 [Abstract] [Full Text] [Related]
4. T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. van Stipdonk MJ, Willems AA, Verbeek R, Boog CJ, van Noort JM. Cell Immunol; 2000 Sep 15; 204(2):128-34. PubMed ID: 11069720 [Abstract] [Full Text] [Related]
5. Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. Kel JM, de Geus ED, van Stipdonk MJ, Drijfhout JW, Koning F, Nagelkerken L. Int Immunol; 2008 Jan 15; 20(1):117-27. PubMed ID: 18024466 [Abstract] [Full Text] [Related]
6. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Kel J, Oldenampsen J, Luca M, Drijfhout JW, Koning F, Nagelkerken L. Am J Pathol; 2007 Jan 15; 170(1):272-80. PubMed ID: 17200200 [Abstract] [Full Text] [Related]
7. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance. Kennedy KJ, Smith WS, Miller SD, Karpus WJ. J Immunol; 1997 Jul 15; 159(2):1036-44. PubMed ID: 9218627 [Abstract] [Full Text] [Related]
8. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. Kennedy MK, Tan LJ, Dal Canto MC, Miller SD. J Immunol; 1990 Jul 01; 145(1):117-26. PubMed ID: 2358669 [Abstract] [Full Text] [Related]
9. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis. Ben-Nun A, Yossefi S, Lehmann D. Eur J Immunol; 1993 Mar 01; 23(3):689-96. PubMed ID: 8095458 [Abstract] [Full Text] [Related]
10. Oral testosterone in male rats and the development of experimental autoimmune encephalomyelitis. Macció DR, Calfa G, Roth GA. Neuroimmunomodulation; 2005 Mar 01; 12(4):246-54. PubMed ID: 15990455 [Abstract] [Full Text] [Related]
11. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis. Szczepanik M, Tutaj M, Bryniarski K, Dittel BN. J Neuroimmunol; 2005 Jul 01; 164(1-2):105-14. PubMed ID: 15899524 [Abstract] [Full Text] [Related]
12. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo. Lange C, Doster H, Steinbach K, Kalbacher H, Scholl M, Melms A, Bischof F. Brain Behav Immun; 2009 Aug 01; 23(6):861-7. PubMed ID: 19362139 [Abstract] [Full Text] [Related]
13. OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207. Kaushansky N, Hemo R, Eisenstein M, Ben-Nun A. Eur J Immunol; 2007 Jul 01; 37(7):2018-31. PubMed ID: 17549734 [Abstract] [Full Text] [Related]
14. Native, but not genetically inactivated, pertussis toxin protects mice against experimental allergic encephalomyelitis. Robbinson D, Cockle S, Singh B, Strejan GH. Cell Immunol; 1996 Mar 15; 168(2):165-73. PubMed ID: 8640862 [Abstract] [Full Text] [Related]
15. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Katsara M, Deraos S, Tselios TV, Pietersz G, Matsoukas J, Apostolopoulos V. Immunotherapy; 2014 Mar 15; 6(6):709-24. PubMed ID: 25186603 [Abstract] [Full Text] [Related]
16. AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic. Wang C, Chou YK, Rich CM, Link JM, Afentoulis ME, van Noort JM, Wawrousek EF, Offner H, Vandenbark AA. J Neuroimmunol; 2006 Jul 15; 176(1-2):51-62. PubMed ID: 16844233 [Abstract] [Full Text] [Related]
17. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ, Kennedy KJ, Smith WS, Miller SD. J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901 [Abstract] [Full Text] [Related]
18. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R. Eur J Immunol; 2009 Jun 15; 39(6):1671-81. PubMed ID: 19499521 [Abstract] [Full Text] [Related]
19. Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis. Galazka G, Stasiolek M, Walczak A, Jurewicz A, Zylicz A, Brosnan CF, Raine CS, Selmaj KW. J Immunol; 2006 Feb 01; 176(3):1588-99. PubMed ID: 16424188 [Abstract] [Full Text] [Related]
20. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Verbeek R, van Tol EA, van Noort JM. Biochem Pharmacol; 2005 Jul 15; 70(2):220-8. PubMed ID: 15946653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]